ARCHIVES

In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office

This article is from The Cancer Letter archive.

Vol. 16 No. 29 | July 20, 1990

Download PDF Visit The Full Archive

Related Articles

Also: Court Will Reconsider Ruling on Access To Experimental Drugs.

December 1, 2006

EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure.

March 2, 2007

In Brief: NCI Can Proceed With Grant, Contract Awards At Full FY 1978 Level; Rundles Heads ACS

November 18, 1977

RFPs Available

May 5, 2000

Resource Offered for DNA Probe Mapping

August 14, 1987

Hawaiian Have Highest Cancer Rate In U.S.

April 29, 1983